Research ArticleHead and Neck Imaging
Evaluation of Head and Neck Squamous Cell Carcinoma After Treatment
Suresh K. Mukherji and Gregory T. Wolf
American Journal of Neuroradiology October 2003, 24 (9) 1743-1746;

References
- ↵Greene FL, Page DL, Fleming ID, eds. American Joint Committee on Cancer Manual for Staging of Cancer. 6th ed. Philadelphia: Lippincott-Raven;2002 :18
- ↵Lapela M, Eigtved A, Jyrkkio S, et al. Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 2000;36:858–867
- ↵Hudgins PA, Burson JG, Gussack GS, Grist WJ. CT and MR appearance of recurrent malignant head and neck neoplasms after resection and flap reconstruction. AJNR Am J Neuroradiol 1994;15:1689–1694
- ↵
- ↵Mukherji SK, Gapany M, Phillips D, et al. Thallium-201 single-photon emission CT versus CT for the detection of recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol 1999;20:1215–1220
- ↵Valdes Olmos RA, Balm AJM, Hilgers FJM, et al. Tl-201 SPECT in the diagnosis of head and neck cancer. J Nucl Med 1997;38:873–879
- Di Martino E, Nowak B, Hassam H, at al. Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emisson tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg 2000;126:1457–1461
- ↵
- ↵Mukherji SK, Mancuso AA, Kotzur IM, et al. Radiographic appearance of the irradiated larynx. Part II. Primary site response. Radiology 1994;193:149–154
- ↵Glazer HS, Niemeyer DM, Balfe DM, et al. Neck neoplasms: MR imaging. Part II. Posttreatment evaluation. Radiology 1986;160:349–354
- ↵
- ↵Loevner LA, Sonners AI, Schulman BJ, et al. Reinterpretation of cross-sectional images in patients with head and neck cancer in the setting of a multidisciplinary cancer center. AJNR Am J Neuroradiol 2002;23:1622–1626
- ↵Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2- [F-18] fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996;200:135–141.
- ↵Bailet JW, Sercarz JA, Abemayor E, et al. The use of positron emission tomography for early detection of recurrent head and neck carcinoma in postradiotherapy patients. Laryngoscope 1995;105:135–139
- Farber LA, Benard F, Machtay M, et al. Detection of recurrent head and neck squamous cell carcinoma after radiation therapy with 2–18F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope 1999;109:970–975
- Fischbein NJ, Aassar OS, Caputo GR, et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol 1998;19:1189–1196
- Greven KM, Williams DW III, Keyes JW Jr, et al. Distinguishing tumor recurrence from irratiation sequelae with positron emission tomography in patients treated for larynx cancer. Int J Radiat Oncol Biol Phys 1994;29:841–845
- Hanasono MM, Kunda LD, Segall GM, et al. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 1999;109:880–885
- Keyes JW Jr, Watson NE Jr, Williams DW III, et al. FDG PET in head and neck cancer. AJR Am J Roentgenol 1997;169:1663–1669
- Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18] fluoro-2-deoxy-D-glucose. Radiology 1995;197:205–211
- Manolidis S, Donald PJ, Valk P, Pounds TR. The use of positron emission tomography scanning in occult and recurrent head and neck cancer. Acta Otolaryngol Suppl (Stockh) 1998;534:1–11
- Paulus P, Sambon A, Vivegnis D, et al. 18FDG PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients. Laryngoscope 1998;108:1578–1583
- Rege S, Maass A, Chaiken L, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancer. Cancer 1994;73:3047–3058.
- ↵
- ↵Nowak B, DiMartino E, Janicke S, et al. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI. Nuklearmedizin 1999;38:312–318
- ↵
- ↵Nagamachi S, Jinnouchi S, Flores LG, et al. The use of Tl-201 SPECT to predict the response to radiotherapy in patients with head and neck cancer. Nuc Med Comm 1996;17:935–942
- ↵Gregor T, Valdes-Olmes RA, Koops W, et al. Preliminary experience with thallous chloride Tl 201-labeled single-photon emission computed tomography scanning in head and neck cancer. Arch Otolaryngol Head Neck Surg 1996;122:509–514
- ↵Chong J, Chan L, Langstein HN, Ginsberg LE. MR imaging of the muscular component of myocutaneous flaps in the head and neck. AJNR Am J Neuroradiol 2001;22:170–174
In this issue
Advertisement
Suresh K. Mukherji, Gregory T. Wolf
Evaluation of Head and Neck Squamous Cell Carcinoma After Treatment
American Journal of Neuroradiology Oct 2003, 24 (9) 1743-1746;
0 Responses
Related Articles
- No related articles found.
Cited By...
- Detection of Local Recurrence in Patients with Head and Neck Squamous Cell Carcinoma Using Voxel-Based Color Maps of Initial and Final Area under the Curve Values Derived from DCE-MRI
- MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter
- Comparison between computed tomography and clinical evaluation in tumour/node stage and follow-up of oral cavity and oropharyngeal cancer
- Diffusion Magnetic Resonance Imaging: A Biomarker for Treatment Response in Oncology
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement